NCT05255939

Brief Summary

The site of arterial access for coronary angiography and intervention has been the focus of research for decades as it is the source of major complications. Transradial access (TRA) reduces complications among patients undergoing percutaneous coronary procedures but is reported with the complication of radial artery occlusion (RAO) that limits the radial artery for future needs. Distal radial access (dTRA) has recently gained global popularity as an alternative access route for vascular procedures. Among the benefits of dTRA are the low risk of entry site bleeding complications, the low rate of radial artery occlusion, and improved patient and operator comfort. This study aims to reveal the feasibility and safety of dTRA and routine TRA procedures in acute coronary syndrome patients. The primary endpoints are forearm radical occlusion rate and major adverse cardiovascular events (MACEs) in the two groups, respectively. Investigators will also focus on puncture success in diagnostic and interventional cases, rate of One attempt success, access time, procedure time, crossover rate, contrast dose of patients, fluoroscopy time and dose, and healthcare cost of each group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 25, 2022

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

February 25, 2022

Status Verified

February 1, 2022

Enrollment Period

1.9 years

First QC Date

January 17, 2022

Last Update Submit

February 24, 2022

Conditions

Keywords

Distal Radial AccessRadial Artery OcclusionMajor Adverse Cardiovascular Events

Outcome Measures

Primary Outcomes (2)

  • Forearm radical occlusion

    Doppler ultrasound to determine whether patients suffer forearm radial occlusion

    during procedure

  • MACEs

    Major Adverse Cardiovascular Events, including cardiovascular death, myocardial infarction and heart failure.

    during procedure

Secondary Outcomes (8)

  • Rate of One attempt success

    during procedure

  • Access time

    during procedure

  • Procedure time

    during procedure

  • Crossover rate

    during procedure

  • Contrast dose

    during procedure

  • +3 more secondary outcomes

Study Arms (2)

dTRA group

EXPERIMENTAL

Investigators perform percutaneous coronary intervention by dTRA

Procedure: distal TRA group

TRA group

OTHER

Investigators perform percutaneous coronary intervention by conventional TRA

Procedure: conventional TRA group

Interventions

dTRA for PCI procedure to ACS patients.

dTRA group

Conventional TRA for PCI procedure to ACS patients

TRA group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presence of a pulse in the snuffbox

You may not qualify if:

  • Absence of pulse
  • Ultrasound indication of arterial occlusion or severe calcification
  • Severe forearm artery malformation
  • Patients with severe liver and renal failure, or abnormal coagulation function
  • Established cardiogenic shock
  • History of previous coronary artery bypass grafting and radial artery use.
  • Raynaud's disease in the medical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shenzhen People's hospital

Shenzhen, Guangdong, 518000, China

Location

MeSH Terms

Conditions

Acute Coronary SyndromeArterial Occlusive Diseases

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2022

First Posted

February 25, 2022

Study Start

March 1, 2022

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

February 25, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations